RexCeptor Inc.

Location

New York, NY, USA

Current Organization

Alzheimer’s Drug Discovery Foundation

Grants

Alzheimer's Disease Research

A Randomized Controlled Study to Evaluate the Effect of Bexarotene, an RXR Agonist, on Amyloid Beta

Active Dates

August 15, 2012 - August 14, 2013

Principal Investigator

RexCeptor Inc.

Current Organization

Alzheimer’s Drug Discovery Foundation

View All Grants